Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

R.C. Coombes; L.S. Kilburn; C.F. Snowdon; R. Paridaens; R.E. Coleman; S.E. Jones; J. Jassem; C.J. Van de Velde; T. Delozier; I. Alvarez; L. Del Mastro; O. Ortmann; K. Diedrich; A.S. Coates; E. Bajetta; S.B. Holmberg; D. Dodwell; E. Mickiewicz; J. Andersen; P.E. Lonning; G. Coccini; J. Forbes; M. Castiglione; N.S. Stuart; A. Stewart; L.J. Fallowfield; G. Bertelli; E. Hall; R.G. Bogle; M. Carpentieri; E. Colajori; M. Subar; E. Ireland; J.M. Bliss

doi:10.1016/S0140-6736(07)60200-1

Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

R.C. Coombes
, L.S. Kilburn
, C.F. Snowdon
, R. Paridaens
, R.E. Coleman
, S.E. Jones
, J. Jassem
, C.J. Van de Velde
, T. Delozier
, I. Alvarez
, L. Del Mastro
, O. Ortmann
, K. Diedrich
, A.S. Coates
, E. Bajetta
, S.B. Holmberg
, D. Dodwell
, E. Mickiewicz
, J. Andersen
, P.E. Lonning

G. Coccini, J. Forbes, M. Castiglione, N.S. Stuart, A. Stewart, L.J. Fallowfield, G. Bertelli, E. Hall, R.G. Bogle, M. Carpentieri, E. Colajori, M. Subar, E. Ireland, J.M. Bliss

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	559-570
Cyfnodolyn	The Lancet
Cyfrol	369
Rhif cyhoeddi	9561
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1016/S0140-6736(07)60200-1
Statws	Cyhoeddwyd - 1 Chwef 2007

Mynediad at Ddogfen

10.1016/S0140-6736(07)60200-1

Dyfynnu hyn

Coombes, R. C., Kilburn, L. S., Snowdon, C. F., Paridaens, R., Coleman, R. E., Jones, S. E., Jassem, J., Van de Velde, C. J., Delozier, T., Alvarez, I., Del Mastro, L., Ortmann, O., Diedrich, K., Coates, A. S., Bajetta, E., Holmberg, S. B., Dodwell, D., Mickiewicz, E., Andersen, J., ... Bliss, J. M. (2007). Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. The Lancet, 369(9561), 559-570. https://doi.org/10.1016/S0140-6736(07)60200-1

@article{0f5ba21c18914752aab4ac898cf0ea03,

title = "Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.",

keywords = "MEDICINE, GENERAL \& INTERNAL",

author = "R.C. Coombes and L.S. Kilburn and C.F. Snowdon and R. Paridaens and R.E. Coleman and S.E. Jones and J. Jassem and \{Van de Velde\}, C.J. and T. Delozier and I. Alvarez and \{Del Mastro\}, L. and O. Ortmann and K. Diedrich and A.S. Coates and E. Bajetta and S.B. Holmberg and D. Dodwell and E. Mickiewicz and J. Andersen and P.E. Lonning and G. Coccini and J. Forbes and M. Castiglione and N.S. Stuart and A. Stewart and L.J. Fallowfield and G. Bertelli and E. Hall and R.G. Bogle and M. Carpentieri and E. Colajori and M. Subar and E. Ireland and J.M. Bliss",

year = "2007",

month = feb,

day = "1",

doi = "10.1016/S0140-6736(07)60200-1",

language = "English",

volume = "369",

pages = "559--570",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "9561",

}

Coombes, RC, Kilburn, LS, Snowdon, CF, Paridaens, R, Coleman, RE, Jones, SE, Jassem, J, Van de Velde, CJ, Delozier, T, Alvarez, I, Del Mastro, L, Ortmann, O, Diedrich, K, Coates, AS, Bajetta, E, Holmberg, SB, Dodwell, D, Mickiewicz, E, Andersen, J, Lonning, PE, Coccini, G, Forbes, J, Castiglione, M, Stuart, NS, Stewart, A, Fallowfield, LJ, Bertelli, G, Hall, E, Bogle, RG, Carpentieri, M, Colajori, E, Subar, M, Ireland, E & Bliss, JM 2007, 'Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.', The Lancet, cyfrol. 369, rhif 9561, tt. 559-570. https://doi.org/10.1016/S0140-6736(07)60200-1

TY - JOUR

T1 - Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

AU - Coombes, R.C.

AU - Kilburn, L.S.

AU - Snowdon, C.F.

AU - Paridaens, R.

AU - Coleman, R.E.

AU - Jones, S.E.

AU - Jassem, J.

AU - Van de Velde, C.J.

AU - Delozier, T.

AU - Alvarez, I.

AU - Del Mastro, L.

AU - Ortmann, O.

AU - Diedrich, K.

AU - Coates, A.S.

AU - Bajetta, E.

AU - Holmberg, S.B.

AU - Dodwell, D.

AU - Mickiewicz, E.

AU - Andersen, J.

AU - Lonning, P.E.

AU - Coccini, G.

AU - Forbes, J.

AU - Castiglione, M.

AU - Stuart, N.S.

AU - Stewart, A.

AU - Fallowfield, L.J.

AU - Bertelli, G.

AU - Hall, E.

AU - Bogle, R.G.

AU - Carpentieri, M.

AU - Colajori, E.

AU - Subar, M.

AU - Ireland, E.

AU - Bliss, J.M.

PY - 2007/2/1

Y1 - 2007/2/1

KW - MEDICINE

KW - GENERAL & INTERNAL

U2 - 10.1016/S0140-6736(07)60200-1

DO - 10.1016/S0140-6736(07)60200-1

M3 - Article

SN - 0140-6736

VL - 369

SP - 559

EP - 570

JO - The Lancet

JF - The Lancet

IS - 9561

ER -